281-296-7300

  • Awards
  • Careers
logo
  • About
    • About VGXI
    • Leadership
    • VGXI Mission
    • Awards
    • Careers
  • Services
    • Manufacturing Services
    • cGMP Plasmid
    • HD Plasmid
    • Pre-Clinical Plasmid
    • Additional Services
  • VGXI Process
    • VGXI Manufacturing Process
    • Analytical Testing
    • Quality Systems
  • Resource Center
    • News
    • Events
    • FAQs
    • Whitepapers
    • Posters & Presentations
  • Contact Us
  • Awards
  • Careers

VGXI Official Statement Regarding COVID-19

VGXI Official Statement Regarding COVID-19

March 19, 2021

A Message from VGXI Regarding the Coronavirus (COVID-19) Outbreak and VGXI Actions

LAST UPDATED March 19, 2021

To our Valued Clients and Business Partners,

VGXI recognizes your concerns regarding the potential impact of the coronavirus outbreak on our products and services. VGXI is actively monitoring the situation and will continue to provide updates as new information becomes available.

At this time, the VGXI facility is continuing operations and manufacturing activities are proceeding as scheduled. The materials and planning teams are in constant contact with our suppliers to proactively identify and address potential impacts to incoming materials or equipment. The VGXI Leadership Team has also evaluated and implemented appropriate measures to ensure the safety of our employees and business continuity.

Specifically, VGXI is taking the following precautionary steps:

  • VGXI has increased communications with all suppliers and is closely monitoring changes in lead times
  • VGXI has identified critical raw materials and secured additional on-site inventory, as needed
  • VGXI has taken steps to manage the supply for critical PPE including gowning materials
  • VGXI has increased internal safety precautions and policies for elevated hygiene
  • VGXI has increased the frequency of facility cleaning and disinfection for both process and common areas
  • VGXI has implemented policies to promote social distancing and remote work for employees where possible
  • VGXI has implemented a mask policy within the facility

VGXI received notice from some of its testing vendors of potential impacts to testing timelines as they take precautionary measures to minimize person to person contact while maintaining operations. As information becomes available, VGXI will promptly communicate possible changes to disposition timelines to specific clients.

Our top priority is to continue delivering the highest quality DNA products and services while ensuring the security and safety of our team. VGXI will continue to closely monitor the coronavirus situation and keep our clients and partners informed of any changes to the current operation status.

Thank you for your continued partnership. Please Contact Us if you have any questions.

Sincerely,
Dorothy Peterson
Chief Operating Officer
VGXI, Inc.

Filed Under: Blog, Events, Media, News, Sticky Post

Archives

  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • About
  • Services
  • VGXI Process
  • Contact Us
  • Careers
  • Awards
  • Resource Center
logo white

281-296-7300
2700 Research Forest Drive, Suite 180
The Woodlands, Texas 77381, USA

Please enter your name.
Please enter a valid email address.
Sign Up

Thanks for subscribing! Please check your email for further instructions.

Something went wrong. Please check your entries and try again.

© 2021 VGXI, Inc. All Rights Reserved.Terms | Privacy Policy

The VGXI Website is set to allow the use of cookies. Cookies help us to give you the best experience on our website. By clicking Accept or continuing to use the site, you agree to use our cookies. If you decline we will not track your information but your browsing experience might be limited. Please visit our Terms and Conditions and our Privacy Policy for more information.AcceptDecline